The Board proposes to update the existing language in this rule to add new pharmaceutical agents.

Notice of Development of Rulemaking

DEPARTMENT OF HEALTH

Board of Optometry

463.005 FS., 463.0055(2)(a) FS.

64B13-18.002 Formulary of Topical Ocular Pharmaceutical Agents.

The topical ocular pharmaceutical formulary consists of pharmaceutical agents which a certified optometrist is qualified to administer and prescribe in the practice of optometry pursuant to Section 463.0055(2)(a), F.S. The topical ocular pharmaceutical agents in the formulary include the following legend drugs alone or in combination in concentrations up to those specified, or any lesser concentration that is commercially available:

(1) through (4) No change.

(5) NON-STEROIDAL AND STEROIDAL ANTI-INFLAMMATORY AGENTS

(a) through (l) No change.

(m) Bromfenac 0.09%

(n) Nopafenac 0.1%

(o) Brimonidine tartrate 0.1%

(6) through (9) No change.

Specific Authority 463.005, 463.0055(2)(a) FS. Law Implemented 463.0055 FS. History–New 3-30-87, Amended 4-5-88, 5-7-90, Formerly 21-18.002, Amended 5-10-92, 1-29-93, Formerly 21Q-18.002, Amended 8-31-93, 7-30-94, Formerly 61F8-18.002, Amended 2-11-96, 4-21-96, 1-12-97, 6-8-97, Formerly 59V-18.002, Amended 6-15-00, 6-7-05, ________.